NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/14/2025
Back to search
Official data from USPTO
STERLING PATHOLOGY NATIONAL LABORATORIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STERLING PATHOLOGY NATIONAL LABORATORIES
ST13
US500000085833806Class
42
Filing
85833806
Registration
4682486
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
12/09/2025
Trademark type
Word
Nice classes
42
Filing date
01/28/2013
Registration date
02/03/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/22/2003
First use in commerce
01/22/2003
Drawing code
4
Owner type
03
Owner location
Seal Beach, CA
Examiner
BERNS,LEE ANNE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Michael S. Doll ADVANTAGE IP LAW FIRM
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical laboratory servicesdiagnosticsanalysisreport generation services relating to the field of pathology
Publications
History of USPTO decisions and trademark events.
40 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/14/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/14/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/29/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/03/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/03/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/03/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2021
E815
TEAS SECTION 8 & 15 RECEIVED
02/02/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/30/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/28/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/15/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/11/2014
IUAF
USE AMENDMENT FILED
11/12/2014
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/13/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2014
PUBO
PUBLISHED FOR OPPOSITION
03/18/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/11/2014
ALIE
ASSIGNED TO LIE
02/11/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2014
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/20/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/05/2013
GNSL
LETTER OF SUSPENSION E-MAILED
12/05/2013
CNSL
SUSPENSION LETTER WRITTEN
12/05/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2013
GNRT
NON-FINAL ACTION E-MAILED
05/10/2013
CNRT
NON-FINAL ACTION WRITTEN
05/10/2013
DOCK
ASSIGNED TO EXAMINER
05/10/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2013
NWAP
NEW APPLICATION ENTERED
01/31/2013
Continuous trademark protection
Get notified about every new filing that threatens STERLING PATHOLOGY NATIONAL LABORATORIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.